+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
From
From
Monoclonal Antibodies for Oncology: Global Markets - Product Thumbnail Image

Monoclonal Antibodies for Oncology: Global Markets

  • Report
  • February 2026
  • 229 Pages
  • Global
From
Hyaluronic Acid in Healthcare: Global Markets - Product Thumbnail Image

Hyaluronic Acid in Healthcare: Global Markets

  • Report
  • September 2025
  • 114 Pages
  • Global
From
From
Hair Diseases Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Hair Diseases Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Crohn's Disease (CD) Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Crohn's Disease (CD) Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
From
Moderate Psoriasis Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Moderate Psoriasis Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more